Caplin Point Laboratories Intrinsic Value
Caplin Point Laboratories (CAPLIPOINT) median intrinsic value is ₹3354.67 from 10 valuation models (range ₹825–₹5497), vs current price ₹2748.60 — +22.1% upside (Trading Below Calculated Value), margin of safety 18.1%. See Caplin Point Laboratories P/B ratio trends to compare market price against book value per share.
CAPLIPOINT Valuation Methods Summary — DCF, Graham Number & P/E
Caplin Point Laboratories intrinsic value across 10 models vs current price ₹2748.60 — upside/downside and value range per method. For current market price and key ratios, visit CAPLIPOINT share price.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹1969.44 | ₹1575.55 - ₹2363.33 | -28.3% | EPS: ₹89.52, Sector P/E: 22x |
| Book Value Method | asset | ₹4841.33 | ₹4357.20 - ₹5325.46 | +76.1% | Book Value/Share: ₹2420.67, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹3354.67 | ₹3019.20 - ₹3690.14 | +22.1% | Revenue/Share: ₹1677.33, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹5497.20 | ₹4947.48 - ₹6046.92 | +100.0% | EBITDA: ₹932.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹4172.56 | ₹3338.05 - ₹5007.07 | +51.8% | CF Growth: 11.6%, Discount: 15% |
| PEG Ratio Method | growth | ₹824.58 | ₹742.12 - ₹907.04 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹1383.08 | ₹1244.77 - ₹1521.39 | -49.7% | Revenue Growth: 6.0%, Adj P/E: 15.5x |
| ROE Based Valuation | profitability | ₹5497.20 | ₹4947.48 - ₹6046.92 | +100.0% | ROE: 19.1%, P/E Multiple: 14x |
| Graham Defensive Method | conservative | ₹2208.10 | ₹1987.29 - ₹2428.91 | -19.7% | EPS: ₹89.52, BVPS: ₹2420.67 |
| Dividend Yield Method | dividend | ₹824.58 | ₹742.12 - ₹907.04 | -70.0% | DPS: ₹8.00, Target Yield: 2.5% |
CAPLIPOINT Intrinsic Value vs Market Price — All Valuation Models
Caplin Point Laboratories fair value range ₹825–₹5497 vs current market price ₹2748.60 across 10 valuation models. Check Caplin Point Laboratories marketcap in USD to track the company's total market size over time.
CAPLIPOINT Intrinsic Value Analysis — Undervalued or Overvalued?
Caplin Point Laboratories median intrinsic value ₹3354.67, current price ₹2748.60 — Trading Below Calculated Value by 22.1%, margin of safety 18.1%.
What is the intrinsic value of CAPLIPOINT?
Based on our comprehensive analysis using 10 different valuation methods, the estimated intrinsic value of Caplin Point Laboratories (CAPLIPOINT) is ₹3354.67 (median value). With the current market price of ₹2748.60, this represents a +22.1% variance from our estimated fair value.
The valuation range spans from ₹824.58 to ₹5497.20, indicating ₹824.58 - ₹5497.20.
Is CAPLIPOINT undervalued or overvalued?
Based on our multi-method analysis, Caplin Point Laboratories (CAPLIPOINT) appears to be trading below calculated value by approximately 22.1%.
CAPLIPOINT Financial Health — Key Ratios vs Industry Benchmarks
Caplin Point Laboratories financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 89.17 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 19.1% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 34.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.62x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
CAPLIPOINT Cash Flow Quality — Operating & Free Cash Flow
Caplin Point Laboratories operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹523 Cr | ₹232 Cr | Positive Free Cash Flow | 7/10 |
| March 2025 | ₹432 Cr | ₹266 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹318 Cr | ₹159 Cr | Positive Free Cash Flow | 7/10 |
| March 2023 | ₹271 Cr | ₹163 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹337 Cr | ₹149 Cr | Positive Free Cash Flow | 7/10 |